Concept Foundation contributes to new regulatory guidance released by WHO for ensuring quality of Oxytocin in LMICs

WHO publishes for the first time a set of dedicated regulatory guidelines for national medicines authorities in low-and middle-income countries (LMICs) to evaluate and set quality standards for oxytocin, an essential maternal health drug used for the prevention and...

PT Tunggal, Indonesia, achieves WHO Prequalification of its intra-muscular injectable contraceptive Triclofem®.

Concept Foundation is delighted to report that PT Tunggal, (PTT) Indonesia has been awarded WHO Prequalification of Triclofem®, their intramuscular (IM) depot medroxyprogesterone acetate (DMPA) 150 mg/ml product. This adds a third generic DMPA product to the list...

“The Case for Quality” report

Following the highly successful “Incentivising Investments in Quality Medicines” event at the World Health Assembly, USP and partners in the #MedsWeCanTrust Campaign have released a report into the learnings from the event.  As a #MedsWeCanTrust partner, we are happy to share the report: The Case for Quality.